Tegoprazan vs. proton pump inhibitors for erosive esophagitis: a superior alternative or just another option? A systematic review and meta-analysis of randomized controlled trials
GastroenterologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- European journal of gastroenterology & hepatology
- Publicado em
- 29 out 2025
- Citações
- 2
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Tegoprazan vs. proton pump inhibitors for erosive esophagitis: a superior alternative or just another option? A systematic review and meta-analysis of randomized controlled trials
Muhammad Anas Nayyer, Hamna Rasool, Hassan Murtaza, Muhammad Rehman Safdar, Suchna Meeral Khan, Salman Khalid, Mohammad Umer
Descritores MeSH
- Esophagitis
- Esophagitis, Peptic
- Proton Pump Inhibitors
- Humans
- Pyrroles
- Sulfonamides
- Randomized Controlled Trials as Topic
- Treatment Outcome
- Esophagoscopy
Veja também
Estudos relacionados
- Potassium-competitive acid blockers and proton-pump inhibitors for the healing and maintenance of erosive esophagitis: a comprehensive and updated systematic review with network meta-analysis
- Vonoprazan Versus Lansoprazole in the Healing and Maintenance Phase of Erosive Esophagitis: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
- Network Meta-Analysis of Comparing Different Dosages of Potassium-Competitive Acid Blocker With Proton-Pump Inhibitor in Acid-Related Disorders
- Vonoprazan is superior to lansoprazole for healing of severe but not mild erosive esophagitis: A systematic review with meta-analysis of randomized controlled trials